Related Experiment Video
Updated: Jul 22, 2026

In Vitro Assessment of Cardiac Function Using Skinned Cardiomyocytes
Published on: June 22, 2020
Altered expression of myosin heavy chain in human skeletal muscle in chronic heart failure
M J Sullivan1, B D Duscha, H Klitgaard
1Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
Insights
Chronic heart failure (CHF) significantly alters skeletal muscle myosin heavy chain (MHC) isoform expression, with reduced MHC type I and increased MHC type IIx. These changes may indicate a specific myopathy beyond deconditioning in CHF patients.
Area of Science:
- Cardiology
- Skeletal Muscle Physiology
- Biochemistry
Background:
- Skeletal muscle alterations are observed in chronic heart failure (CHF).
- Myosin heavy chain (MHC) isoforms are key determinants of muscle fiber function.
- Understanding MHC isoform changes in CHF is crucial for comprehending exercise intolerance.
Purpose of the Study:
- To investigate alterations in MHC isoform composition in the vastus lateralis skeletal muscle of patients with CHF.
- To correlate MHC isoform expression with exercise capacity (peak oxygen consumption).
Main Methods:
- Biopsies of vastus lateralis muscle were obtained from nine male patients with class II-III CHF and nine age-matched healthy males.
- Relative content of MHC isoforms (I, IIa, IIx) was quantified using gel electrophoresis.
- Expression levels were compared between CHF patients and normal controls.
Main Results:
- CHF patients exhibited significantly lower relative content of MHC type I compared to normal controls (24% vs 48.4%).
- CHF patients showed a higher relative content of MHC type IIx than normal controls (20% vs 6.5%).
- No significant difference was found in MHC type IIa content between groups.
- Three out of nine CHF patients had undetectable MHC type I.
- Relative MHC type I expression in CHF patients correlated positively with peak oxygen consumption (r=0.70).
Conclusions:
- Significant alterations in MHC isoform expression, specifically a reduction in MHC type I and an increase in MHC type IIx, are present in skeletal muscle of CHF patients.
- These changes suggest a potential specific skeletal muscle myopathy in CHF, not solely attributable to deconditioning.
- MHC isoform alterations may contribute to impaired skeletal muscle contractile function and reduced exercise performance in CHF.
Abstract:
To explore further alterations in skeletal muscle in chronic heart failure (CHF), we examined myosin heavy chain (MHC) isoforms from biopsies of the vastus lateralis in nine male patients with class II-III (CHF) (left ventricular ejection fraction (LVEF) 26 +/- 11%, peak oxygen consumption (peak VO2) 12.6 +/- 2 mL.kg-1.min-1) and nine age-matched sedentary normal males (NL). The relative content of MHC isoforms I, IIa, and IIx was determined by gel electrophoresis as follows: The normal sedentary group (NL) had a higher percent of MHC type I when compared with the patients (NL 48.4 +/- 7% vs CHF patients 24 +/- 21.6%, P < 0.05, no difference between MCH IIa (NL 45.1 +/- 10.5% vs CHF 56.0 +/- 12.5%), and CHF patients had a higher relative content of MHC type IIx than did the normal group (NL 6.5 +/- 9.6% vs CHF 20.0 +/- 12.9%, P < 0.05. Three of nine patients had no detectable MHC type I. In patients relative expression of MHC type I (%) was related to peak VO2 (r = 0.70, P < 0.05). Our results indicate that major alterations in MHC isoform expression are present in skeletal muscle in CHF. These alterations parallel previously reported changes in fiber typing that may affect contractile function i skeletal muscle and possibly exercise performance. The absence of MHC type I in some CHF patients suggests that skeletal muscle changes in this disorder are not solely a result of deconditioning, buy may reflect a specific skeletal muscle myopathy in this disorder.
Related Concept Videos
Pathophysiology of Heart Failure
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Myocarditis I: Introduction
Heart Failure I: Introduction
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy

